Executive VP & Worldwide Chairman of MedTech, Johnson & Johnson
Search every verified Timothy Schmid interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Tim Schmid, Executive Vice President and Worldwide Chairman of MedTech at Johnson & Johnson, discussed the company's recently FDA-approved TECNIS PureSee™ intraocular lens in a conversation with ophthalmologist Dr. Matt Hirabayashi. During the discussion, Schmid highlighted the lens's availability in the U.S. after prior international use and emphasized its potential to reduce patients' reliance on glasses following cataract surgery. He also described the technology as part of a broader shift toward a "refractive first" approach to cataract treatment, moving beyond traditional lens replacement and corrective eyewear. Schmid also addressed the importance of delivering consistent, high-quality outcomes in vision care, drawing an analogy to aviation safety practices such as checklists and resource management. He underscored the trust patients place in surgeons and expressed a commitment to earning that trust through innovations like TECNIS PureSee.
Join J&J MedTech’s Executive Vice President & Worldwide Chairman Tim Schmid for a chat with Dr. Matt Hirabayashi – one of the surgeons involved in our study for TECNIS PureSee™ IOL, which recently received FDA-approval.
Join @jnjmedtech's Executive Vice President & Worldwide Chairman Tim Schmid for a chat with Dr. Navin K. Kapur, who spent years treating heart failure patients with our Impella™ heart pumps before becoming our Heart Recovery team’s Chief Medical and Scientific Officer.
In this episode of DeviceTalks Weekly, we hear from two of MedTech’s most powerful leaders, each representing different ends of the innovation timeline. Tim Schmid, executive vice president and worldwide chairman of Johnson & Johnson MedTech, lays out the global leaders plan to lead in cardiovascular, surgery, vision, surgical robotics and other high growth businesses. Schmid opened our DeviceTalks West conference last month where he was interviewed by Host Tom Salemi. Thank you to [Vantedge Medical](https://vantedgemedical.com/) for sponsoring this episode. For more information on how Vanted…
Join Johnson & Johnson MedTech’s Executive Vice President & Worldwide Chairman Tim Schmid as he sits down with Dr. Devin Sasser to chat about the latest innovation from our Vision team: the ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM. As one of the first eye care professionals to fit patients with the new lens, Dr. Sasser shares his impressions of his patients’ responses to the lens, and how innovation like this is closing gaps in care that have existed for far too long. Read more: https://bit.ly/4oT7dSj
Sign in to search the full transcript archive, filter by topic, and access every quote from Timothy Schmid.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans